Lincoln Pharmaceuticals Ltd Performance
Open
554.6
Traded Value (Cr)
2.12 Cr
Prev. Close
551.8
VWAP
563.38
Volume
36,876
Face Value
10
Lincoln Pharmaceuticals Ltd Fundamentals
Lincoln Pharmaceuticals Ltd Financials
Resistance and Support
₹587.58
PIVOT
Resistance | |
---|---|
First Resistance | ₹594.067 |
Second Resistance | ₹602.433 |
Third Resistance | ₹608.917 |
Support | |
---|---|
First Resistance | ₹579.217 |
Second Resistance | ₹572.733 |
Third Resistance | ₹564.367 |
RSI | 37.216 |
MACD | -6.574 |
ADX | 20.906 |
CCI | -207.618 |
Delivery and Volume
About Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project. The Company launched Next Generation Progesterone Therapy 'ProlinSpray' during the year 2018. During the year 2021-22, Lincoln Parenteral Limited (Transferor Company), an erstwhile subsidiary, merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this, the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.
Managing Director
Mahendra G Patel
Founded
1995
NSE Symbol
LINCOLN
Lincoln Pharmaceuticals Ltd Management
Name | Designation |
---|---|
Kishorbhai M Shah | Chairman (Non-Executive) |
Mahendra G Patel | Managing Director |
Hasmukhbhai I Patel | Whole-time Director |
Pirabhai R Suthar | Independent Director |
Munjal Mahendrabhai Patel | Whole-time Director |
Aashish R Patel | Whole-time Director |
Meha Patel | Independent Director |
Saurin J Parikh | Independent Director |
Rajnikant G Patel | Director |
Anand Arvindbhai Patel | Whole-time Director |
Trusha Shah | Company Sec. & Compli. Officer |